RxDoctor Payments Data

Kasey McCreight, MD

Family Medicine · Pueblo, CONPI 1730329731

Payments from drug & device makers

$351in general payments, 2019–2025

Across 15 payments — averaging $23.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$109
  • E.r. Squibb & Sons, L.L.C.$37
  • Pfizer$26
  • AbbVie$24
  • GSK$23
  • Novo Nordisk$21
  • plus $111 from 7 others

What the payments were for

  • Food & beverage$24169%
  • Education$10931%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$351 in reported general payments places this provider in the 65th percentile of 2,079 family medicine providers in Colorado.

See all family medicine providers in Colorado

Medicare billing

Part B allowed, 2024
$710
Medicare patients
26
Services billed
43

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide163$194,759
EliquisApixaban108$129,805
XareltoRivaroxaban83$92,471
TrulicityDulaglutide35$55,361
Trelegy ElliptaFluticasone/Umeclidin/Vilanter45$50,245
MounjaroTirzepatide35$49,642
LinzessLinaclotide49$36,065
JardianceEmpagliflozin15$24,590
Victoza 3-PakLiraglutide20$23,527
Repatha SureclickEvolocumab15$22,848
JanuviaSitagliptin Phosphate19$21,276
Spiriva RespimatTiotropium Bromide16$18,587
Tresiba Flextouch U-200Insulin Degludec12$12,646
MyrbetriqMirabegron11$11,697
Spiriva HandihalerTiotropium Bromide12$10,407

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$21$194,759163 claims
PfizerEliquis$26$129,805108 claims
GSKTrelegy Ellipta, Anoro Ellipta$23$59,72466 claims
AbbVieLinzess, Synthroid$24$41,523115 claims
Astellas Pharma US IncMyrbetriq$18$11,69711 claims
AstraZenecaSymbicort$12$6,71811 claims
Teva Pharmaceuticals USA, Inc.Qvar Redihaler$109$4,70815 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 2,079 family medicine providers in Colorado.

Other family medicine in Pueblo

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →